Quality Pledge: Made in an FSSAI inspected facility to meet the stringent standards of US Pharmacopeia (USP) for quality, purity, potency and disintegration
East Asia: In East Asia, China and Japan are experiencing strong demand for GLP-1 receptor agonists, driven by an increasing prevalence of type 2 diabetes and expanding access to diabetes treatments
Oxidation threatens methionine and tryptophan residues specifically
It works by: Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain to reduce hunger and food cravings Improving insulin secretion in response to elevated blood glucose levels Reducing glucagon secretion , which helps regulate blood sugar Wegovy is administered as a once-weekly subcutaneous injection
A retrospective medical database analysis of T2D patients (n = 39,275) treated with exenatide or other glucose-lowering therapies (n = 381,218) indicated that the GLP-1 agonist might reduce in 19% the incidence of MACCE and in 12% cardiovascular hospitalizations [71]
(21) It is highly stable, remaining intact in gastric juice for over 24 hours, and has a strong safety profile (no lethal dose identified)
